Also trades as: DRMAW (NASDAQ) · $vol 0M
DRMA NASDAQ
Dermata Therapeutics, Inc.
1W: -2.6%
1M: -13.3%
3M: -17.2%
YTD: -49.1%
1Y: -78.4%
3Y: -93.2%
5Y: -99.9%
$1.10
-0.01 (-0.45%)
Weekly Expected Move ±4.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$8M
+37.9% ▲
Net Income
-$8M
+38.5% ▲
EPS (Diluted)
$-8.16
+89.8% ▲
EBITDA
-$8M
+36.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $3M | $6M | $4M | $8M | $2.9B |
| SG&A Expenses | $4M | $4M | $4M | $4M | $4.8B |
| Operating Expenses | $8M | $10M | $8M | $13M | $8M |
| Operating Income | -$8M | -$10M | -$8M | -$13M | -$8M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $46K | -$64K | $0 | $0 | $0 |
| Income Before Tax | -$8M | -$10M | -$8M | -$12M | -$8M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8M | -$10M | -$8M | -$12M | -$8M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-152.70 | $-139.20 | $-399.81 | $-80.32 | $-8.16 |
| EBITDA | -$8M | -$10M | $247K | -$12M | -$8M |
| Shares Outstanding | 52053 | 69066 | 19496 | 153000 | 926192 |